Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI

Geschäftsbericht 2025
hinzugefügt 31.03.2026

report update icon

Brainstorm Cell Therapeutics Langfristiger Schuldenstrom 2011-2026 | BCLI

Langfristiger Schuldenstrom Jährlich Brainstorm Cell Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
208 K 549 K 603 K 1.43 M 1.46 M 2.66 M 1.26 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.66 M 208 K 1.17 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.89 1.48 % $ 6.54 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.2 -2.07 % $ 3.68 B usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
716 K $ 0.75 -4.66 % $ 27.9 M israelIsrael
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Galapagos NV Galapagos NV
GLPG
1.73 M $ 27.87 -1.94 % $ 2.69 B belgiumBelgium
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
85.5 K $ 8.41 0.72 % $ 75.9 M usaUSA
Innoviva Innoviva
INVA
418 K $ 23.04 -2.74 % $ 1.55 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 100.87 -1.17 % $ 27.2 B germanyGermany
Kamada Ltd. Kamada Ltd.
KMDA
2.12 M $ 8.17 0.25 % $ 260 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.05 -0.98 % $ 433 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 22.46 -3.56 % $ 2.86 B usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
2 K $ 6.33 -5.6 % $ 181 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.41 -5.07 % $ 375 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.98 2.76 % $ 4.91 M israelIsrael
Madrigal Pharmaceuticals Madrigal Pharmaceuticals
MDGL
1.02 M $ 516.16 -0.1 % $ 11.6 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany